TY - JOUR T1 - Characterization of the Novel Human Serotonin Receptor Subunits 5-HT<sub>3C</sub>,5-HT<sub>3D</sub>, and 5-HT<sub>3E</sub> JF - Molecular Pharmacology JO - Mol Pharmacol SP - 8 LP - 17 DO - 10.1124/mol.106.032144 VL - 72 IS - 1 AU - Beate Niesler AU - Jutta Walstab AU - Sandra Combrink AU - Dorothee Möller AU - Johannes Kapeller AU - Jens Rietdorf AU - Heinz Bönisch AU - Manfred Göthert AU - Gudrun Rappold AU - Michael Brüss Y1 - 2007/07/01 UR - http://molpharm.aspetjournals.org/content/72/1/8.abstract N2 - Within the family of serotonin receptors, the 5-hydroxytryptamine-3 (5-HT3) receptor is the only ligand-gated ion channel. It is composed of five subunits, of which the 5-HT3A and 5-HT3B subunits are best characterized. Several studies, however, have reported on the functional diversity of native 5-HT3 receptors, which cannot solely be explained on the basis of the 5-HT3A and 5-HT3B subunits. After our discovery of further putative 5-HT3 serotonin receptor-encoding genes, HTR3C, HTR3D, and HTR3E, we investigated whether these novel candidates and the isoform 5-HT3Ea are able to form functional 5-HT3 receptor complexes. Using immunofluorescence and immunoprecipitation studies of heterologously expressed proteins, we found that each of the respective candidates coassembles with 5-HT3A. To investigate whether the novel subunits modulate 5-HT3 receptor function, we performed radioligand-binding assays and calcium-influx studies in human embryonic kidney 293 cells. Our experiments revealed that the 5-HT3C,5-HT3D, 5-HT3E, and 5-HT3Ea subunits alone cannot form functional receptors. Coexpression with 5-HT3A, however, results in the formation of functional heteromeric complexes with different serotonin efficacies. Potencies of two agonists and antagonists were nearly identical with respect to homomeric 5-HT3A and heteromeric complexes. However, 5-HT showed increased efficacy with respect to 5-HT3A/D and 5-HT3A/E receptors, which is consistent with the increased surface expression compared with 5-HT3A receptors. In contrast, 5-HT3A/C and 5-HT3A/Ea receptors exhibited decreased 5-HT efficacy. These data show for the first time that the novel 5-HT3 subunits are able to form heteromeric 5-HT3 receptors, which exhibit quantitatively different functional properties compared with homomeric 5-HT3A receptors. The American Society for Pharmacology and Experimental Therapeutics ER -